Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: May 19, 2025, 4:00 PM
2.010
0.00 (0.00%)
After-hours: May 19, 2025, 4:15 PM EDT

Edesa Biotech Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
Net Income
-5.84-6.17-8.37-17.55-13.34-6.36
Upgrade
Depreciation & Amortization
0.160.190.180.120.120.06
Upgrade
Stock-Based Compensation
0.350.541.252.263.20.6
Upgrade
Other Operating Activities
--0.01----
Upgrade
Change in Accounts Receivable
0.710.360.562.03-3.230.13
Upgrade
Change in Accounts Payable
-1.150.02-0.560.88-0.121
Upgrade
Change in Other Net Operating Assets
0.040.20.3-0.02-0.28-0.4
Upgrade
Operating Cash Flow
-5.72-4.89-6.64-12.28-13.66-4.99
Upgrade
Capital Expenditures
----0.01-0.01-0
Upgrade
Sale of Property, Plant & Equipment
-----0.05
Upgrade
Sale (Purchase) of Intangibles
------0.03
Upgrade
Investing Cash Flow
----0.01-0.010.02
Upgrade
Long-Term Debt Issued
-----0.03
Upgrade
Total Debt Issued
-----0.03
Upgrade
Long-Term Debt Repaid
--0.03----
Upgrade
Net Debt Issued (Repaid)
--0.03---0.03
Upgrade
Issuance of Common Stock
7.640.735.1211.9614.367.6
Upgrade
Other Financing Activities
-0.6-0.11-0.29-0.33-0.19-0.53
Upgrade
Financing Cash Flow
16.920.594.8311.6314.177.09
Upgrade
Foreign Exchange Rate Adjustments
-0.1-0.030.08-0.090.120.06
Upgrade
Net Cash Flow
11.1-4.32-1.73-0.750.632.18
Upgrade
Free Cash Flow
-5.72-4.89-6.64-12.28-13.67-4.99
Upgrade
Free Cash Flow Margin
------1518.00%
Upgrade
Free Cash Flow Per Share
-1.52-1.53-2.32-5.86-7.92-4.06
Upgrade
Levered Free Cash Flow
-3.57-3.16-3.78-6.12-14.93-2.66
Upgrade
Unlevered Free Cash Flow
-3.57-3.16-3.78-6.12-14.93-2.66
Upgrade
Change in Net Working Capital
0.23-0.5-0.55-2.993.44-0.72
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q